医学
癌症
医疗保健
生活质量(医疗保健)
家庭医学
大流行
梅德林
护理部
重症监护医学
2019年冠状病毒病(COVID-19)
疾病
内科学
政治学
传染病(医学专业)
法学
经济
经济增长
作者
Michael Jefford,Doris Howell,Qiuping Li,Karolina Lisy,Jane Maher,Catherine M. Alfano,Meg Rynderman,Jon Emery
出处
期刊:The Lancet
[Elsevier]
日期:2022-04-01
卷期号:399 (10334): 1551-1560
被引量:66
标识
DOI:10.1016/s0140-6736(22)00306-3
摘要
The number of survivors of cancer is increasing substantially. Current models of care are unsustainable and fail to address the many unmet needs of survivors of cancer. Numerous trials have investigated alternate models of care, including models led by primary-care providers, care shared between oncology specialists and primary-care providers, and care led by oncology nurses. These alternate models appear to be at least as effective as specialist-led care and are applicable to many survivors of cancer. Choosing the most appropriate care model for each patient depends on patient-level factors (such as risk of longer-term effects, late effects, individual desire, and capacity to self-manage), local services, and health-care policy. Wider implementation of alternative models requires appropriate support for non-oncologist care providers and endorsement of these models by cancer teams with their patients. The COVID-19 pandemic has driven some changes in practice that are more patient-centred and should continue. Improved models should shift from a predominant focus on detection of cancer recurrence and seek to improve the quality of life, functional outcomes, experience, and survival of survivors of cancer, reduce the risk of recurrence and new cancers, improve the management of comorbidities, and reduce costs to patients and payers. This Series paper focuses primarily on high-income countries, where most data have been derived. However, future research should consider the applicability of these models in a wider range of health-care settings and for a wider range of cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI